{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:07:53Z","timestamp":1788930473269,"version":"build-2803163510"},"reference-count":57,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.1080\/21645515.2024.2396220","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T12:16:52Z","timestamp":1726143412000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Policies for the immunization against serogroup B meningococcus for adolescents immunized during the first two years of life: A mini review"],"prefix":"10.1080","volume":"20","author":[{"given":"Claudia","family":"Palmieri","sequence":"first","affiliation":[{"name":"University of Bari Aldo Moro","place":["Bari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Moscara","sequence":"additional","affiliation":[{"name":"University of Bari Aldo Moro","place":["Bari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Tafuri","sequence":"additional","affiliation":[{"name":"University of Bari Aldo Moro","place":["Bari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3279-0196","authenticated-orcid":false,"given":"Pasquale","family":"Stefanizzi","sequence":"additional","affiliation":[{"name":"University of Bari Aldo Moro","place":["Bari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"European Medicines Agency (EMA). Bexsero. Annex I summary of product characteristics; 2024 [accessed 2024 May 24]. 1:32 p.m. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/bexsero-epar-product-information_en.pdf."},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-013-0029-2"},{"key":"e_1_3_3_4_1","unstructured":"European Medicines Agency (EMA). Trumenba. Annex I summary of product characteristics. 2024 [accessed 2024 May 24]. 1:37 p.m. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/trumenba-epar-product-information_en.pdf."},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2016.1203238"},{"key":"e_1_3_3_6_1","unstructured":"GlaxoSmithKline (GSK). Annual report 2023 [accessed 2024 May 24]. https:\/\/www.gsk.com\/media\/11007\/annual-report-2023.pdf."},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-023-00836-8"},{"key":"e_1_3_3_8_1","unstructured":"U.S. Food and Drug Administration (FDA). Bexsero. 2024 [accessed 2024 May 24]. 1:47 p.m. https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/bexsero."},{"key":"e_1_3_3_9_1","unstructured":"Australian Government Department of Health and Aged Care Therapeutic Good Administration. Public summary \u2013 Bexsero. 2024 [accessed 2024 May 24]. 3:17 p.m. https:\/\/www.ebs.tga.gov.au\/servlet\/xmlmillr6?dbid=ebs\/PublicHTML\/pdfStore.nsf&docid=190718&agid=%28PrintDetailsPublic%29&actionid=1."},{"key":"e_1_3_3_10_1","unstructured":"GlaxoSmithKline (GSK). Product monograph including patient medication information \u2013 BEXSERO. 2024 [accessed 2024 May 24]. 2:43 p.m. https:\/\/ca.gsk.com\/media\/6309\/bexsero.pdf."},{"key":"e_1_3_3_11_1","unstructured":"U.S. Food and Drug Administration (FDA). Package insert - Bexsero. [accessed 2024 May 24]. 3:24 p.m. https:\/\/www.fda.gov\/media\/90996\/download."},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7315a4"},{"key":"e_1_3_3_13_1","unstructured":"U.S. Food and Drug Administration (FDA). Trumenba. 2024 [accessed 2024 May 24]. 3:36 p.m.https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/trumenba."},{"key":"e_1_3_3_14_1","unstructured":"European Medicines Agency (EMA). Trumenba. 2024 [accessed 2024 May 24]. 3:38 p.m. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/trumenba."},{"key":"e_1_3_3_15_1","unstructured":"European Medicines Agency (EMA). Trumenba. Annex I summary of product characteristics. 2024 [accessed 2024 May 24]. 2:49 p.m."},{"key":"e_1_3_3_16_1","unstructured":"Australian Government Department of Health and Aged Care. Australian immunization handbook. Trumenba. 2024 [accessed 2024 May 24]. 3:42 p.m. https:\/\/immunisationhandbook.health.gov.au\/vaccines\/trumenba."},{"key":"e_1_3_3_17_1","unstructured":"U.S. Food and Drug Administration (FDA). Package insert - Trumenba. 2024 [accessed 2024 May 24]. 3:47 p.m. https:\/\/www.fda.gov\/media\/89936\/download?attachment."},{"key":"e_1_3_3_18_1","unstructured":"Pfizer. Product monograph including patient medication information \u2013 TRUMENBA. 2024 [accessed 2024 May 24]. 2:48 p.m.https:\/\/www.pfizer.ca\/files\/Trumenba_PM_EN.pdf."},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268823000328"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1458175"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.7416\/ai.2019.2277"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2015.09.035"},{"key":"e_1_3_3_23_1","unstructured":"European Centre for Disease Prevention and Control (ECDC). Scientific advice \u2013 expert opinion on the introduction of the meningococcal B (4CMenB) vaccine in the EU\/EEA. 2017 Dec 6 [accessed 2024 May 24]. 3:52 p.m. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Introduction-of-4CMenB-vaccine.pdf."},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.04.101"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2022.2021881"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/20477724.2021.1972663"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00754-4"},{"key":"e_1_3_3_28_1","unstructured":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2020.1857201."},{"key":"e_1_3_3_29_1","unstructured":"Centers for Disease Control and Prevention (CDC). Vaccines and preventable diseases - meningococcal vaccination: what everyone should know. 2024 [accessed 2024 May 24]. 3:56 p.m. https:\/\/www.cdc.gov\/vaccines\/vpd\/mening\/public\/index.html."},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2041359"},{"key":"e_1_3_3_31_1","unstructured":"Asl Roma 2. Vaccinazioni \u2013 modalit\u00e0 di Offerta. 2024 May 24. 3:58 p.m. https:\/\/www.aslroma2.it\/attachments\/article\/311\/partecipazione%20ticket%20vaccini.pdf."},{"key":"e_1_3_3_32_1","unstructured":"Government of Canada. Meningococcal vaccines: Canadian immunization guide for health professionals. 2024 [accessed 2024 May 24]. 4:03 p.m. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-4-active-vaccines\/page-13-meningococcal-vaccine.html#routine."},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2021.04.031"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00666-15"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.04.085"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30048-3"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.29218"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1086\/656741"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.28666"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31829cfff2"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001056"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61961-8"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.12.059"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.06.005"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.20473"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.2011652"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.09.061"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1528831"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2007.10.002"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1979846"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.29678"},{"key":"e_1_3_3_52_1","unstructured":"Centers for Disease Control and Prevention (CDC). Vaccines and preventable diseases - meningococcal vaccination for adolescents: information for healthcare professionals. 2024 [accessed 2024 May 31]. 1:10 p.m. https:\/\/www.cdc.gov\/vaccines\/vpd\/mening\/hcp\/adolescent-vaccine.html#:~:text=Anyone%20can%20get%20meningococcal%20disease increased%20risk%20for%20meningococcal%20disease."},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2019.1580579"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1627159"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.01.018"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.17.17-00468"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1547606"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6764154"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2024.2396220","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T16:52:09Z","timestamp":1744649529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2024.2396220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"alternative-id":["10.1080\/21645515.2024.2396220"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2024.2396220","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-06-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2396220"}}